This might be due to the possibility that FBXO7 is frequently downregulated in HCC patients by the mutation of TP53 or other tumor suppressor genes, leading to high PRMT1 protein abundance to support HCC development. Here, FBXO7 is linked to hepatocellular carcinoma.